Prospective Randomized 3-Arm Trial Comparing Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus with Calcineurin inhibitor-Free Immunosuppression (Sirolimus/MMF) after Heart Transplantation

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 27 Nov 2015

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Tacrolimus (Primary) ; Tacrolimus (Primary) ; Antithymocyte globulin; Methylprednisolone; Mycophenolate mofetil; Mycophenolate mofetil; Prednisone; Sirolimus
Indications Heart transplant rejection
Focus Therapeutic Use

07 Nov 2012 5-year results presented at the 85th Annual Scientific Sessions of the American Heart Association.
19 Jul 2012 5-year results presented at the 24th International Congress of the Transplantation Society.
11 May 2012 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com